FDA 510(k)

Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System

Numéro K : K163406 · 2017-07-11

Date de décision2017-07-11

Code produitCHH

Comité consultatifCH

DécisionSubstantially Equivalent

Résumé du dispositif

Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System is the device name listed in this FDA 510(k) record. The listed applicant is ACON Laboratories, Inc.. It received FDA 510(k) clearance on 2017-07-11 under 510(k) number K163406. The device is classified under product code CHH. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Questions fréquentes

What is the Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System?

Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System is a medical device that received FDA 510(k) clearance on 2017-07-11. The listed applicant is ACON Laboratories, Inc.. The 510(k) number is K163406.

When did Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System receive FDA 510(k) clearance?

Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System received FDA 510(k) clearance on 2017-07-11, under 510(k) number K163406.

Who is the listed applicant for Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System?

The FDA 510(k) record lists ACON Laboratories, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System?

The FDA product code for Mission Cholesterol Monitoring System, Mission Cholesterol Pro Monitoring System is CHH.

Essais cliniques associés

Les enregistrements connexes sont mis en correspondance automatiquement à l'aide des noms, codes produits ou autres métadonnées. Une mise en correspondance n'établit pas de relation clinique, scientifique, corporative ou réglementaire vérifiée ; veuillez consulter les sources officielles liées.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Autres dossiers indiquant ACON Laboratories, Inc. en tant que demandeur

K261212Flowflex Plus RSV + Flu A/B + COVID Rapid Test K251697Flowflex® Plus Strep A Rapid Test Cassette; Flowflex® Plus Strep A Rapid Test Strip K251749Flowflex Plus RSV + Flu A/B + COVID Home Test K250085On Call® Sure GK Blood Glucose & Ketone Monitoring System; On Call® Sure Sync GK Blood Glucose & Ketone Monitoring System K250377Flowflex Plus COVID-19 + Flu A/B Home Test K232715Distinct® Digital Pregnancy Test

Voir tous les 16 dispositifs →

Dispositifs connexes (Code : CHH)

K251091LipidsTruvian Health K232404CHOLESTEROL; HDL-cholesterol ; LDL-cholesterol; TRIGLYCERIDESMedicon Hellas S.A K203597Cholesterol2Abbott Ireland Diagnostics Division K190490VITROS XT Chemistry Products TRIG-CHOL SlidesOrtho-Clinical Diagnostics, Inc.K181373Extended Lipid Panel AssayLaboratory Corporation of America Holdings K180504Mission Lipid Panel Monitoring SystemACON Laboratories, Inc.

Source officielle

Voir dans la base de données FDA →

Données issues de l'API ouverte de la FDA. Pour les informations les plus récentes et faisant autorité, veuillez toujours vous référer au registre officiel.